"Splenic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SPLEEN.
Descriptor ID |
D013160
|
MeSH Number(s) |
C04.588.842 C15.604.744.680
|
Concept/Terms |
Splenic Neoplasms- Splenic Neoplasms
- Neoplasm, Splenic
- Splenic Neoplasm
- Neoplasms, Splenic
- Spleen Neoplasms
- Neoplasm, Spleen
- Neoplasms, Spleen
- Spleen Neoplasm
Cancer of Spleen- Cancer of Spleen
- Spleen Cancers
- Splenic Cancer
- Cancer, Splenic
- Cancers, Splenic
- Splenic Cancers
- Cancer of the Spleen
- Spleen Cancer
- Cancer, Spleen
- Cancers, Spleen
|
Below are MeSH descriptors whose meaning is more general than "Splenic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Splenic Neoplasms".
This graph shows the total number of publications written about "Splenic Neoplasms" by people in this website by year, and whether "Splenic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 1 | 2 |
1999 | 1 | 1 | 2 |
2001 | 1 | 2 | 3 |
2002 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 2 | 1 | 3 |
2006 | 3 | 0 | 3 |
2007 | 2 | 2 | 4 |
2008 | 2 | 0 | 2 |
2009 | 3 | 1 | 4 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 4 | 1 | 5 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 4 | 1 | 5 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Splenic Neoplasms" by people in Profiles.
-
Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy. Front Immunol. 2024; 15:1366271.
-
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma. Transplant Cell Ther. 2024 May; 30(5):516.e1-516.e10.
-
Solitary palpable breast mass as the initial presentation of clinically silent extramedullary acute myeloid leukemia. Breast J. 2020 02; 26(2):267-268.
-
Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. Hum Pathol. 2018 04; 74:5-16.
-
Distinguishing Between Hepatosplenic T-cell Lymphoma and ?d T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol. 2017 01; 41(1):82-93.
-
Laparoscopic Partial Splenectomy for Unknown Primary Cancer: A Stepwise Approach. Ann Surg Oncol. 2017 Apr; 24(4):1134.
-
Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-a inhibitor therapy and literature review. Ann Diagn Pathol. 2017 Feb; 26:16-22.
-
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. Br J Cancer. 2016 08 09; 115(4):442-53.
-
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial. Ann Surg Oncol. 2016 12; 23(13):4169-4177.
-
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol. 2016 May; 40(5):676-88.